Your session is about to expire
← Back to Search
Methylphenidate for ADHD
Study Summary
This trial is looking at using brain scans to predict how well someone with ADHD will respond to treatment with methylphenidate, and to measure the changes in task-related neural activity and brain glutamate levels after treatment.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 4 trial • 267 Patients • NCT02039908Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You must be right-handed.I have a history of neurological disorders.I have had a head injury with unconsciousness or lasting problems in the past year.I have a health condition that is not well-managed.You had a bad reaction to methylphenidate or any other medication that stimulates the body.You are currently a smoker.My cognitive issues are not due to ADHD.
- Group 1: Placebo first
- Group 2: Methylphenidate first
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do I have the required prerequisites to be included in this experiment?
"To qualify for this study, applicants must have an ADHD diagnosis and be between 18 to 40 years old. This trial is accepting up to 30 participants in total."
What is the maximum capacity for enrollees to this research project?
"Indeed, clinicaltrials.gov's data confirms that this medical experiment is presently seeking participants, having been first published on July 27th 2021 and last updated on October 6th 2022. The trial seeks to enrol 30 individuals from one centre."
Are individuals of a younger age able to participate in this experiment?
"Participants of this trial must be between the age brackets of 18 and 40. For those outside these ages, there are 15 trials for minors aged under 18 and 13 studies accommodating patients over 65 years old."
Has there been any other research involving Methylphenidate prior to this current trial?
"At present, there are 29 clinical trials investigating the efficacy of Methylphenidate with two studies in Phase 3. Most research centres for this medication can be found in Lexington, Kentucky; however, 42 different sites across the nation have active trials for it."
Is participation in this research available to the public?
"Affirmative. According to clinicaltrials.gov, this ongoing study is calling for volunteers and was initially posted on the 27th July 2021 with its most recent edit taking place on October 6th 2022. Currently, 30 participants are needed at a single research facility."
Has Methylphenidate been certified by the FDA?
"The safety of Methylphenidate is rated 3, as this drug has already been approved and the current trial is in its fourth phase."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Johns Hopkins School of Medicine: < 24 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger